Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Secondary hyperparathyroidism develops when something outside the parathyroid glands, most often chronic kidney disease, vitamin D deficiency, or poor calcium absorption, pushes blood calcium down and signals the glands to release extra parathyroid hormone (PTH). PTH then works to rescue calcium three ways: pulling it from bone, reclaiming more of it in the kidneys, and activating vitamin D so the gut absorbs more, which is why calcium often looks normal on labs while PTH and phosphate do not. That rescue comes at a cost, and over time it can thin bone and cause fatigue, bone or joint pain, fractures, and muscle weakness. Because the underlying cause, kidney function, and lab pattern all change what happens next, there are several important details to consider before assuming your results are harmless, so read the complete answer below.
Since these symptoms overlap with anemia, thyroid disease, and many other conditions, taking a free, instant, online sympt
Calcium is vital for strong bones, healthy muscles and nerves, and a steady heartbeat. When blood calcium levels dip too low, the body springs into action—chiefly by boosting parathyroid hormone (PTH) to pull calcium back into balance. This compensatory process, known as secondary hyperparathyroidism, can occur in conditions like vitamin D deficiency, chronic kidney disease and rickets. Understanding how PTH “rescues” blood calcium helps patients and doctors identify causes, monitor treatment and prevent complications.
Even a small drop in blood calcium prompts the parathyroid glands—four tiny glands behind the thyroid—to release more PTH.
PTH is the body’s rapid response team for low calcium. When blood levels fall below the tight normal range (~8.5–10.2 mg/dL), PTH secretion ramps up. Its goals: increase calcium in the bloodstream and restore balance.
Key actions of PTH:
Bone Matrix Breakdown
Kidney Effects
Gastrointestinal Uptake
Through these coordinated actions, PTH can restore blood calcium but at the expense of bone density if the stimulus persists.
Rickets is a childhood bone disease marked by soft, weak bones and skeletal deformities. The most common form is nutritional rickets due to vitamin D deficiency. In this context:
Patients with secondary hyperparathyroidism may notice:
Key laboratory patterns:
Effective treatment targets the underlying cause:
With proper therapy, PTH levels can normalize, symptoms improve and further bone loss is minimized.
If you experience persistent bone pain, muscle weakness, unexplained fatigue or have a condition like CKD, you might benefit from a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Regular medical follow-up is crucial. Controlling PTH and maintaining balanced calcium and phosphate levels helps prevent bone deformities, fractures and cardiovascular complications.
Speak to a doctor about any symptoms that concern you or could be life threatening. Early detection and treatment of secondary hyperparathyroidism protect your bones, muscles and overall health.
(References)
* Carlstedt F, Lind L. Hypocalcemic syndromes. Crit Care Clin. 2001 Jan;17(1):139-53, vii-viii. doi: 10.1016/s0749-0704(05)70156-1. PMID: 11219226.
* Tanaka Y. [Secondary hyperparathyroidism]. Ryoikibetsu Shokogun Shirizu. 2001;(36):303-6. PMID: 11596397.
* Giachini M, Pierleoni F. [Fluoride toxicity]. Minerva Stomatol. 2004 Apr;53(4):171-7. PMID: 15107774.
* Michels TC, Kelly KM. Parathyroid disorders. Am Fam Physician. 2013 Aug 15;88(4):249-57. PMID: 23944728.
* Jain N, Reilly RF. Hungry bone syndrome. Curr Opin Nephrol Hypertens. 2017 Jul;26(4):250-255. doi: 10.1097/MNH.0000000000000327. PMID: 28375869.
* Bove-Fenderson E, Mannstadt M. Hypocalcemic disorders. Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):639-656. doi: 10.1016/j.beem.2018.05.006. Epub 2018 May 28. PMID: 30449546.
* Duque EJ, Elias RM, Moysés RMA. Parathyroid Hormone: A Uremic Toxin. Toxins (Basel). 2020 Mar 17;12(3). doi: 10.3390/toxins12030189. Epub 2020 Mar 17. PMID: 32192220; PMCID: PMC7150960.
* Pepe J, Colangelo L, Biamonte F, Sonato C, Danese VC, Cecchetti V, Occhiuto M, Piazzolla V, De Martino V, Ferrone F, Minisola S, Cipriani C. Diagnosis and management of hypocalcemia. Endocrine. 2020 Sep;69(3):485-495. doi: 10.1007/s12020-020-02324-2. Epub 2020 May 4. PMID: 32367335.
* Palumbo VD, Palumbo VD, Damiano G, Messina M, Fazzotta S, Lo Monte G, Lo Monte AI. Tertiary hyperparathyroidism: a review. Clin Ter. 2021 May 5;172(3):241-246. doi: 10.7417/CT.2021.2322. PMID: 33956045.
* Goto S, Hamano T, Fujii H, Taniguchi M, Abe M, Nitta K, Nishi S. Hypocalcemia and cardiovascular mortality in cinacalcet users. Nephrol Dial Transplant. 2024 Mar 27;39(4):637-647. doi: 10.1093/ndt/gfad213. PMID: 37777840.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.